DRLOGY PATHOLOGY LAB

Accurate | Caring | Instant

105 -108, SMART VISION COMPLEX, HEALTHCARE ROAD, OPPOSITE HEALTHCARE COMPLEX. Habibabad- 689578

www.drlogy.com

Farzana Kousar (H/O: Zeeshan) Sample Collected At:

Age : 29 Years Habibabad
Sex : Female
Ref. By: Dr. Ayesha Gul
PID : 555

HEPATITIS C VIRUS (HCV) RAPID SCREENING

TEST
Investigation Result Reference Value Unit

HCV RAPID SCREENING TEST, Non-reactive

SERUM
ICT
Interpretation :

RESULTS REMARKS

REACTIVE Indicates presence of antibodies to Hepatitis C virus

NON-REACTIVE Indicates absence of antibodies to Hepatitis C virus

* It is recommended to confirm all reactive results with the HCV antibody confirmatory test (S314)*

Note :
1. Reactive test result indicates presence of Hepatitis C virus infection. It cannot differentiate between the stages of Hepatitis C
viral infection nor used to monitor the efficacy of treatment.
2. Non-Reactive test result indicates Hepatitis C virus infection is unlikely.
3. False positive results may be observed in patients receiving mouse monoclonal antibodies, on heparin therapy, on biotin
supplements for diagnosis or therapy or presence of heterothallic antibodies in serum.
4. False negative reaction may be due to processing of sample collected early in the course of disease, Prozone phenomenon,
Immunosuppression & Immuno-incompetence.
5. Test conducted on serum.

Uses :
1. To diagnose suspected HCV infection in risk group.
2. Prenatal Screening of pregnant women and pre surgical/interventional procedures work up.

Thanks for Reference ****End of Report****

Medical Lab Technician Dr. Zafar Shah Dr. Ayesha Gul Shah
(DMLT, BMLT) (MD, Pathologist) (MD, Pathologist)

Generated on : 01 Jan, 2024 03:00 PM Page 1 of 1

Sample Collection 0348432877

 DRLOGY PATHOLOGY LAB
Accurate | Caring | Instant
105 -108, SMART VISION COMPLEX, HEALTHCARE ROAD, OPPOSITE HEALTHCARE COMPLEX. Habibabad- 689578

www.drlogy.com

Farzana Kousar (H/O: Zeeshan) Sample Collected At:

Age : 29 Years Habibabad
Sex : Female
Ref. By: Dr. Ayesha Gul

Activated partial thromboplastin time, APTT

Investigation Result Reference Value Unit
Plasto THrombotime activated
PARTIAL THROMBOPLASTIN 30.00 23.70 - 33.00 Sec
Activated APTT
TIME,
PATIENTACTIVATED VALUE (APTT)
3.00 SEC
Photo optical Clot Detection 28.40 Sec
CONTROL VALUE 2.28 SEC
Patient Value
Note :
1. Degree of prolongation of PTT / APTT is neither predictive of bleeding risk nor underlying diagnosis
2. Results should be clinically correlated
3. Test conducted on Citrated plasma

Partial Thromboplastin time (PTT / APTT) measures the proteins of the intrinsic coagulation pathway which consists of Factor XII,
Prekallikrein, High molecular weight kininogen, Factors VIII, IX & XI. It also measures proteins of the common pathway namely
factors II, V, X & Fibrinogen. PTT is prolonged when Factor VIII level is < 35-40% of normal and Factor XII & High molecular
weight kininogen is < 10-15% of normal.

Abnormal Partial Thromboplastin Time

Associated with bleeding: Defects of factors VIII, IX & XI
Not associated with bleeding: Defects of factor XII, Prekallikrein, High molecular weight kininogen & Lupus anticoagulants

Causes of prolonged PTT / APTT

Liver disease · Consumptive coagulopathy
Circulating anticoagulants including Lupus AnticoagulantOral
Anticoagulant therapy
Factor deficiencies

Thanks for Reference ****End of Report****

Medical Lab Technician Dr. Dr. Zafar Shah Dr. Ayesha Gul Shah
(DMLT, BMLT) (MD, Pathologist) (MD, Pathologist)

Generated on : 01 Jan, 2024 03:00 PM Page 1 of 1

Sample Collection 0348432877

 DRLOGY PATHOLOGY LAB
Accurate | Caring | Instant
105 -108, SMART VISION COMPLEX, HEALTHCARE ROAD, OPPOSITE HEALTHCARE COMPLEX. Habibabad - 689578

www.drlogy.com

Farzana Kousar (H/O: Sample Collected At:

Zeeshan) Habibabad
Age : 29 Years: Ref. By: Dr. Ayesha Gul
Sex: Female
Complete Blood Count (CBC) with ESR
Investigation Result Reference Value Unit
Primary Sample Type : Blood
HEMOGLOBIN
Hemoglobin (Hb) 08 Low 13.0 - 17.0 g/dL
RBC COUNT
Total RBC count 3.2 4.5 - 5.5 mill/cumm

BLOOD INDICES
Packed Cell Volume (PCV) 57.5 High 40 - 50 %
Mean Corpuscular Volume (MCV) 87.75 83 - 101 fL
Calculated

MCH 27.2 27 - 32 pg
Calculated

MCHC 32.8 32.5 - 34.5 g/dL

Calculated

RDW 13.6 11.6 - 14.0 %

WBC COUNT
Total WBC count 9000 4000-11000 cumm
PLATELET COUNT
Platelet Count 150000 Borderline 150000 - 410000 cumm

ESR 5 0 - 15 mm/hr
Capillary photometry

Instruments: Fully automated cell counter - Mindray 300

Interpretation: Further confirm for Anemia

Thanks for Reference ****End of Report****

Medical Lab Technician Dr.Zafar Shah Dr. Ayesha Gul Shah

(DMLT, BMLT) (MD, Pathologist) (MD, Pathologist)

Generated on : 01 Jan, 2024 03:00 PM

Sample Collection 0348432877

 DRLOGY PATHOLOGY LAB 0123456789 | 0912345678

Accurate | Caring | Instant drlogypathlab@drlogy.com

105 -108, SMART VISION COMPLEX, HEALTHCARE ROAD, OPPOSITE HEALTHCARE COMPLEX. MUMBAI - 689578

www.drlogy.com

Yash M. Patel Sample Collected At:

Age : 21 YearsSex 125, Shivam Bungalow, S G Road,
Registered on: 02:31 PM 02 Dec, 2X
: Male Mumbai
Collected on: 03:11 PM 02 Dec, 2X
PID : 555 Ref. By: Dr. Hiren Shah Reported on: 04:35 PM 02 Dec, 2X

Complete Blood Count (CBC)

Investigation Result Reference Value Unit
Primary Sample Type : Blood
HEMOGLOBIN
Hemoglobin (Hb) 12.5 Low 13.0 - 17.0 g/dL
RBC COUNT
Total RBC count 5.2 4.5 - 5.5 mill/cumm

BLOOD INDICES
Packed Cell Volume (PCV) 57.5 High 40 - 50 %
Mean Corpuscular Volume (MCV) 87.75 83 - 101 fL
Calculated

MCH 27.2 27 - 32 pg
Calculated

MCHC 32.8 32.5 - 34.5 g/dL

Calculated

RDW 13.6 11.6 - 14.0 %

WBC COUNT
Total WBC count 9000 4000-11000 cumm

PLATELET COUNT
Platelet Count 150000 Borderline 150000 - 410000 cumm

Instruments: Fully automated cell counter - Mindray 300

Interpretation: Further confirm for Anemia

Thanks for Reference ****End of Report****

Medical Lab Technician Dr. Zafar Shah Dr. Ayesha Gul Shah
(DMLT, BMLT) (MD, Pathologist) (MD, Pathologist)

Generated on : 01 Jan, 2024 03:00 PM

Sample Collection 0348432877

 DRLOGY PATHOLOGY LAB
Accurate | Caring | Instant
105 -108, SMART VISION COMPLEX, HEALTHCARE ROAD, OPPOSITE HEALTHCARE COMPLEX. Habibabad - 689578

www.drlogy.com

Farzana Kousar (H/O: Sample Collected At:

Zeeshan)
Habibabad
Age: 29 Years
Ref. By: Dr. Ayesha Gul
Sex : Female
PID : 555
LIVER FUNCTION TEST
(LFT)
Investigation Result Reference Value Unit
Primary Sample Type : Serum

AST (SGOT) 16.00 15.00 - 40.00 U/L

IFCC without P5P

ALT (SGPT) 150.50 High 10.00 - 49.00 U/L

IFCC without P5P

AST:ALT Ratio 0.50 <1.00

Calculated

GGTP 10.20 0 - 73 U/L

IFCC

Alkaline Phosphatase (ALP) 15.40 Low 30.00 - 120.00 U/L

IFCC-AMP

Bilirubin Total 0.60 0.30 - 1.20 mg/dL

DPD

Bilirubin Direct 0.10 <0.3 mg/dL

DPD

Bilirubin Indirect 0.10 <1.10 mg/dL

Calculated

Albumin 2.00 3.20 - 4.80 g/dL

BCG

A : G Ratio 0.10 0.90 - 2.00 g/dL

Calculated

Note :
1. In an asymptomatic patient, Non alcoholic fatty liver disease (NAFLD) is the most common cause of increased AST, ALT
levels. NAFLD is considered as hepatic manifestation of metabolic syndrome.
2. In most type of liver disease, ALT activity is higher than that of AST; exception may be seen in Alcoholic Hepatitis, Hepatic
Cirrhosis, and Liver neoplasia. In a patient with Chronic liver disease, AST:ALT ratio>1 is highly suggestive of advanced liver
fibrosis.
3. In known cases of Chronic Liver disease due to Viral Hepatitis B & C, Alcoholic liver disease or NAFLD, Enhanced liver
fibrosis (ELF) test may be used to evaluate liver fibrosis.
4. In a patient with Chronic Liver disease, AFP and Des-gamma carboxyprothrombin (DCP)/PIVKA II can be used to assess risk
for development of Hepatocellular Carcinoma.
Thanks for Reference ****End of Report****

Medical Lab Technician Dr. Zafar Shah Dr. Ayesha Gul Shah
(DMLT, BMLT) (MD, Pathologist) (MD, Pathologist)

Generated on : 01 Jan, 2024 03:00 PM

Sample Collection 0348432877